Cargando…

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients

Glioma is the common histological subtype of malignancy in the central nervous system, with high morbidity and mortality. Glioma cancer stem cells (CSCs) play essential roles in tumor recurrence and treatment resistance. Thus, exploring the stem cell-related genes and subtypes in glioma is important...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Jun, Zhu, Hecheng, Tang, Guihua, Liu, Hongwei, Wanggou, Siyi, Cao, Yudong, Xin, Zhaoqi, Zhou, Quanwei, Zhan, Chaohong, Wu, Zhaoping, Guo, Youwei, Jiang, Zhipeng, Zhao, Ming, Ren, Caiping, Jiang, Xingjun, Yin, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957071/ https://www.ncbi.nlm.nih.gov/pubmed/33732284 http://dx.doi.org/10.3389/fgene.2021.616507

Ejemplares similares

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
por: Wu, Zhaoping, et al.
Publicado: (2023)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma
por: Yin, Wen, et al.
Publicado: (2019)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma
por: Zhou, Quanwei, et al.
Publicado: (2021)

Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis
por: Zhou, Quanwei, et al.
Publicado: (2020)

Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma
por: Cao, Yudong, et al.
Publicado: (2022)

The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas
por: Yan, Xuejun, et al.
Publicado: (2021)

Construction and experimental validation of a signature for predicting prognosis and immune infiltration analysis of glioma based on disulfidptosis-related lncRNAs
por: Guo, Youwei, et al.
Publicado: (2023)

Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma
por: Li, Chang, et al.
Publicado: (2020)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
por: Zhou, Yi, et al.
Publicado: (2023)

Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
por: Wu, Ming, et al.
Publicado: (2017)

FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
por: Shen, Wenyue, et al.
Publicado: (2022)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
por: Hu, Yungang, et al.
Publicado: (2023)

Functional characterization of TSPAN7 as a novel indicator for immunotherapy in glioma
por: Chen, Long, et al.
Publicado: (2023)

TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
por: Li, Shasha, et al.
Publicado: (2023)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns
por: Chen, Xueran, et al.
Publicado: (2019)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
por: Zou, Han, et al.
Publicado: (2020)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
por: Kuang, Yirui, et al.
Publicado: (2023)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma
por: Lin, Xuelei, et al.
Publicado: (2022)

Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)

Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury
por: Li, Xing, et al.
Publicado: (2017)

A practical and economical method for frontal sinus reconstruction after frontal craniotomy: A single-center experience with 140 patients
por: Guo, Youwei, et al.
Publicado: (2022)

LncRNAs and their RBPs: How to influence the fate of stem cells?
por: Zhao, Cong, et al.
Publicado: (2022)

Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
por: Hu, Dongzhi, et al.
Publicado: (2023)

Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma
por: Wanggou, Siyi, et al.
Publicado: (2016)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
por: Zhu, Zhenhua, et al.
Publicado: (2020)

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients
por: Ye, Ningrong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ap06r2tsmt6pkqha2ssr9c8p88